Cite

HARVARD Citation

    Voss, T. et al. (2016). A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine. Cephalalgia. pp. 887-898. [Online]. 
  
Back to record